File / Download

The "CHEMOTHERAPY" Upfront Research Report by IDiyas is a comprehensive analytical tool that provides intellectual property insights and competitive intelligence in the oncology field. Rather than a medical treatment, this report offers a strategic deep dive into over 1,500 patents from 1978 to 2025, categorizing key innovations—such as antineoplastic agents, injectable compositions, and antibodies—using the Cooperative Patent Classification (CPC) codes. By identifying key inventors, assignees, and emerging trends like AI-based prognosis and nanotechnology, the product serves as an essential resource for researchers and legal professionals seeking to navigate the complex landscape of cancer treatment innovation.